Evidence map›Paper›PMID 33402361›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy.

Lin Ma, Alba Gonzalez-Junca, Yufei Zheng, Haoxu Ouyang, Irineu Illa-Bochaca, Kathleen C Horst, Gregor Krings, Yinghao Wang, Ignacio Fernandez-Garcia, William Chou and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Lin MaDepartment of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
Alba Gonzalez-JuncaDepartment of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
Yufei ZhengDepartment of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
Haoxu OuyangDepartment of Radiation Oncology, New York University School of Medicine, New York, New York.
Irineu Illa-BochacaDepartment of Radiation Oncology, New York University School of Medicine, New York, New York.
Kathleen C HorstDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, California.ORCID 0000-0003-3883-8848
Gregor KringsDepartment of Pathology, University of California, San Francisco, San Francisco, California.
Yinghao WangDepartment of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
Ignacio Fernandez-GarciaDepartment of Radiation Oncology, New York University School of Medicine, New York, New York.
William ChouDepartment of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.ORCID 0000-0001-8957-3953
Mary Helen Barcellos-HoffDepartment of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. MaryHelen.Barcellos-Hoff@ucsf.edu.ORCID 0000-0002-5994-9558
UCSF Helen Diller Family Comprehensive Cancer Center · USNew York University · USStanford University · USUniversity of California, San Francisco · US

Funding

Contribution of development and age to breast cancer etiologyR01CA190980 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BARCELLOS-HOFF, MARY HELEN · 2015 to 2020
$2.6M
NCI NIH HHS R01 CA190980
6 · The paper itself

Abstract

purposeWomen treated with radiotherapy before 30 years of age have increased risk of developing breast cancer at an early age. Here, we sought to investigate mechanisms by which radiation promotes aggressive cancer. EXPERIMENTAL

designThe tumor microenvironment (TME) of breast cancers arising in women treated with radiotherapy for Hodgkin lymphoma was compared with that of sporadic breast cancers. To investigate radiation effects on carcinogenesis, we analyzed tumors arising from

resultsCompared with age-matched specimens of sporadic breast cancer, radiation-preceded breast cancers (RP-BC) were characterized by TME rich in TGFβ, cyclooxygenase 2, and myeloid cells, indicative of greater immunosuppression, even when matched for triple-negative status. The mechanism by which radiation impacts TME construction was investigated in carcinomas arising in mice bearing

conclusionsThese data show that radiation acts via nonmutational mechanisms to promote markedly immunosuppressive features of aggressive, RP-BCs.

Indexed as

Tumor MicroenvironmentAnimalsApoptosisBreast NeoplasmsCell ProliferationFemaleHumansInflammationInflammatory Breast NeoplasmsMacrophagesMiceMice, Inbred BALB CMice, NudePrognosisRadiotherapyTumor Cells, Cultured

Identifiers

PMID33402361
PMCPMC7956216
OpenAlexW3118308293

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.